Listen to the text Stop the audio


As a result of a pioneering initiative in the pharmaceutical sector, Eurofarma’s first products with the +Verde seal came to market in 2018. This seal identifies drugs with innovative actions capable of generating a positive impact throughout the chain and on the environment.

One of the advantages of products with the +Verde seal is the inner blister packaging, which presents a globally unprecedented methodology developed by Eurofarma and validated by Anvisa for domestic decontamination. The seal also attests to the use of 30% recycled material in the outer packaging (cartridge), as well as extra precautions observed in the production process, such as the economy of inputs and impact control, as well as final consumer awareness on proper disposal.

More than 49.5 million drugs bearing the seal have been marketed in Brazil since 2018 and, as a result, the project has already helped reduce 1.56 tons of carbon equivalent.